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LEARNING OBJECTIVES
1. The ART physician should understand the structure of the Y chromosome, why it
harbors genes required for spermatogenesis, and why it so frequently has deletions which
result in azoospermia and severe oligospermia.
2. The ART physician should understand the pitfalls in interpreting standard Y deletion
testing, and be able to identify those STS markers which are robust and those which could
represent polymorphisms or repeat sequences (false negative and false positive results).
3. The ART physician should have an understanding of the entire range of testis specific
genes whose deletions or mutations are being missed (because of multiple repeats) by
standard screening.
4. The ART physician should understand how to counsel infertile males undergoing ART
regarding transmission of their infertility to ICSI offspring.Silber
PRE-COURSE QUESTIONS
1. Male infertility can be transmitted either to ICSI offspring or to their children:
a. If a Y deletion is detected on routine screening.
b. If an X chromosomal testis-specific gene has a mutation.
c. Possibly in the majority of cases.
d. If the patient has only moderate oligospermia.
e. All of the above.
2. Y chromosome deletions associated with azoospermia:
a. Are generally transmitted to the infertile patient from his father who also has a &
deletion in his peripheral lymphocytes.
b. First occur in the infertile patient’s testes as a spontaneous mutation.
c. First occur in the testes of the infertile patient’s father even though the father’s
sperm are found to have no Y deletions.
d. Result from testicular mosaicism in the infertile patient’s father.
Answers:
1.  E
2.  CSilber
SUMMARY
The purpose of this lecture is to put in perspective the accumulating molecular data on Y
chromosomal, X chromosomal, and autosomal spermatogenesis genes, and the genetic origin of
oligospermia.  The current gene search with simple STS mapping on the Y chromosome is just a
starting point for locating many other spermatogenesis genes that are widespread throughout the
genome.    Now  that  the  Y  has  finally  been  sequenced  (2002),  many  more  genes  are  being
discovered that impact spermatogenesis.
The presence on the Y chromosome of testis specific genes, which arrive from autosomal
homologues, or from persistence of ancestral X genes which eventually  acquire  male  specific
function,  is  a  recurrent  theme  in  the  evolution  of  spermatogenesis  of  all  animals  with  sex
determining  chromosomes.    A  summary  of  the  evolutionary  history  of  our  X  and  Y-
chromosomes explains why the Y chromosome was a good place to start in the molecular search
for spermatogenesis genes.  However, it is clear that numerous genes on the X chromosome as
well, and on autosomes, also impinge on spermatogenesis and may thus be transmitted to  ICSI
offspring.
The presence of Y deletions in azoospermic and severely oligospermic (<2x106) men does
not prevent fertilization or pregnancy either with ICSI, or occasionally with no treatment at all.
The  Y  deletion  (and  presumably  infertility)  is  thereby  transmitted  to  the  male  offspring.
However, there are many spermatogenesis genes involved in male infertility, and we have barely
scratched  the  surface  with  what  have  been  (up  until  very  recently)  very  gross  mapping
techniques.  
Whether or not these currently detectable gross “microdeletions” are found in an infertile
male patient does not obviate the likelihood of there being a genetic cause for his azoospermia or
severe oligospermia.  If a defective gene (or genes) is located on his Y chromosome, then all of the
male offspring will inherit his problem.  However, if genes on the X chromosome are responsible
for the infertility,  then  daughters  will  be  carriers  and  grandsons  may  inherit  the  defect.    If
autosomal dominant genes are the cause of the infertility, then only half of the male offspring will
be infertile, and half of the daughters will be carriers.  There is no way of knowing what effect, if
any at all, the carrier state for male infertility will have on the daughter.
All cases of male infertility need to  be considered genetic until proven otherwise, and
patients so counseled.  A negative Y deletion assay as currently widely practiced, and a normal
46 XY karyotype  does not in any way rule out  that  the infertility is genetically transmissible
(because these techniques have such low resolution).  With sequence-based techniques we are
now identifying many genes that in a polygenic fashion determine the sperm count.  The current
enthusiasm for STS mapping of Y deletions is just a very crude beginning, and is only identifying
huge deletions.  Smaller deletions and point  mutations are certain to  be  much  more  common
causes of male infertility.
EARLY  GENETIC  STUDIES  OF  AZOOSPERMIC  AND  SEVERELY  OLIGOSPERMIC
MEN
For several decades, it had been speculated that  there was a genetic etiology to  many
cases of male infertility (1-2).  This suspicion originally arose from cytogenetic evidence reported
over 25 years ago in a very small percentage (0.2%) of azoospermic men who were otherwise
phenotypically normal, but who had grossly obvious terminal Y chromosome deletions (Fig. 1a,Silber
1b) (3).  Simple  karyotyping  of  infertile  men  also  raised  the  possibility  of  infertility  being
associated with autosomal translocations (4-10).  A massive summary of karyotyping results in
newborn populations,  reviewed by  Van Assche, revealed an  incidence  of  balanced  autosomal
translocations in a normal newborn population of 0.25% but  an incidence of 1.3%, in infertile
men (Table 1A) (4).  In fact, karyotyping of oligospermic males (i.e. less than 20 million per cc)
reveal  a  3%  incidence  of  some  type  of  autosomal  chromosome  anomaly,  either  balanced
Robertsonian  translocations,  balanced  reciprocal  translocations,  balanced  inversions,  or  extra
markers.  These translocations could conceivably be transmitted to  offspring  if  ICSI  allowed
them to conceive.  However, because of the limitations of the resolution of cytogenetics, and the
very  small percentage of these readily discernable karyotypic  abnormalities  found  in  infertile
men,  until  recently  it  had  been  a  convoluted  struggle  to  study  the  genetic  causes  of  male
infertility, and the possible transmission of these genetic errors to the offspring of couples with
male infertility (10).  
The possibility that many more cases of male infertility might be genetic was bolstered
by the failure of most clinical therapies to  correct deficient spermatogenesis (1-2,11-21).  The
heritability  of  sperm  count  demonstrated  in  the  wild  (22-24),  classic  studies  of  naturally
occurring pure sterile Y deletions in Drosophila, and very early molecular investigations of the Y
chromosome in humans led to what has now become an intense search for genes which control
spermatogenesis and which may be defective in many or most infertile males (25-29).  However,
only  recently  has  the  frequent  genetic  etiology  of  male  infertility  related  to  defects  in
spermatogenesis  (not  to  mention  obstruction)  become  widely  acknowledged  via  molecular
methodology  (1,30-39).    If  male  infertility  is  of  genetic  origin,  its  possible  transmission  to
offspring of successfully treated infertile men is a serious social concern (1,40-61).
Y CHROMOSOME MAPPING OF INFERTILE MEN AND ICSI
With simple karyotyping, it has been known that  a very  small number of azoospermic
men (0.2%) have large defects visible in the long arm of the Y chromosome that are not present in
their fertile fathers.  This implied the existence of an azoospermic factor somewhere on Yq. (3).
However, smaller defects (i.e. “microdeletions”) could not be discerned with those limited early
cytogenetic methods (Fig. 1a,1b,1c).  Therefore, defects in Yq were considered to be rare even in
azoospermic men.
In 1992, comprehensive Y  chromosomal  maps  were  constructed  using  yeast  artificial
chromosomes (YACS) and sequenced tagged sites (STS), and this created the possibility for more
detailed study of the Y chromosome in infertile men (62-63).  Using polymerase chain reaction
(PCR), a more refined search for Y  chromosome deletions could be pursued  by  testing for as
many as 52 DNA  landmarks  (STSs,  or  sequence  tagged  sites)  across  the  entirety  of  the  Y
chromosome.  All Y-DNA markers employed were placed on a physical map of the chromosome,
the markers representing all gene families that were then known in the non-recombining region of
the Y  chromosome (35,62-64).  Using these molecular mapping techniques, which have much
greater resolution than cytogenetics, a large series of severely infertile men with clearly identified
phenotypes  revealed deletions in 13% of azoospermic males (36) (Fig. 2).  As  many as 7% of
severely oligospermic men also had these same “microdeletions” (65-66).  The most commonly
deleted region was located in the distal portion of interval 6, subsequently referred to  as AZFc
(Fig. 3a &3b) (65,34,36).  The higher resolution of Y  mapping over karyotyping  thus  showedSilber
that more than just 0.2% of azoospermic men had defects of the Y chromosome, and more than
just a few percent of severely infertile men had a genetic cause for their condition.
However, because of the highly polymorphic nature of the non-recombining region of the
Y (NRY), there are many “Y deletions” that are of no consequence.  Only if these deletions in
the infertile male are not present in his fertile male relatives, nor in hundreds of normal controls,
could they be implicated as a cause of the infertility.  The fertile fathers of the Y-deleted, infertile
men were shown to have intact Y chromosomes, demonstrating that the deletions had arisen de
novo and providing strong evidence that these de novo deletions were indeed the cause of the
spermatogenic failure observed in these men.   Many  laboratories  throughout  the  world  have
reported on these sub-microscopic deletions of the Y chromosome in azoospermic and severely
oligospermic  men  (27,30-35,60,67-93,).    Nonetheless,  even  these  popular,  new  molecular
methodologies were crude (not sequence-based) maps, and were suspected of missing huge areas
of DNA sequence.
The DAZ gene cluster was identified within the most  commonly deleted region, AZFc
(36,94).  DAZ genes were shown in humans to be transcribed specifically in spermatogonia and
early primary spermatocytes (95).  Autosomal DAZ homologues were also found in Drosophila
(the Boule gene), in mice (DAZLA),  and in fact in frogs and even worms (Table  2).    These
autosomal DAZ  gene  homologues were  found  to  be  necessary  for  spermatogenesis  in  every
species studied (28,96-97).  In the human, Y chromosome DAZ, located in the AZFc region, was
found to be in the midst of an area of multiple nucleotide sequence repeats.  It was later found to
be present in four near-identical copies (99.9%) in the AZFc region (98).  The presence on human
chromosome 3 of DAZLA, an autosomal homologue of the human Y chromosomal DAZ, is what
allows  a  small  degree  of  spermatogenesis  to  survive  in  the  majority  of  AZFc-deleted  men.
However, men  with  larger  deletions  that  extended  beyond  AZFc  had  no  sperm  at  all  (65).
Recently it has been shown that smaller deletions, which take out only two copies of DAZ result
in milder spermatogenic defects than the classic AZFc deletion which takes out all four copies of
DAZ (99-100).  This indicates that there is a polygenic dosage effect of multiple genes that might
control spermatogenesis.
Early ICSI studies  showed  a  clear  trend  toward  larger  deletions  causing  more  severe
spermatogenic defects than smaller deletions (65,101).  These studies suggested that  possibly
several  genes  in  different  areas  of  the  Y  chromosome  might  play  an  important  role  in
spermatogenesis.  In fact, some of the earliest studies of deletion on the human Y  chromosome
unveiled a different gene  (RBM)  in the AZFb  region  (27,26,102,64,73).    Although  there  are
numerous copies and pseudogenes of RBM  on the Y, most  of which are nonfunctional, there
appears  to  be  a  functional  copy  in  the  region  just  proximal  to  AZFc,  with  no  “rescue”
homologues elsewhere.  These early results supported the concept, that numerous genes on the Y
chromosome, in addition to  those of the AZFc  region, impinge on spermatogenesis (64).  As
might have been expected, many more genes have now been identified in AZFc and elsewhere on
the  Y  by  detailed  sequencing  studies  (64,102-103).    Thus,  multiple  spermatogenesis  genes
apparently contribute to and modify the severity of the spermatogenic defect in Y-deleted men.
These early deletions on the Y were called “micro” deletions only because they could not
be discerned by  karyotyping.   But  they  were indeed huge deletions (102).    It  was  correctly
hypothesized that smaller deletions, or point mutations might very well be present both in AZFcSilber
and  elsewhere,  but  the  repetitive  nucleotide  sequences  which  characterize  much  of  the  Y
chromosome made it very difficult with standard STS markers to define smaller deletions (104).  
The unusually repetitive sequence structure of the AZFc region of the Y plagued even the
first attempts at constructing a physical map with YAC’s, because repetitive STS’s could not be
accurately placed in what  was then called deletion intervals 6D-6F.  Even the  size  of  AZFc
(without an accurate sequence) was controversial (0.5 to  2 Mb)  (62,105-106).  Efforts to  find
point mutations along the Y chromosome, have also been thwarted by the presence of multiple
copies of genes in these regions with  numerous  Y  specific  repeats  that  in  the  absence  of  a
complete sequence made the detection of specific nucleotide errors almost impossible to detect.
The Y  chromosome, and specifically the most  commonly deleted area, such as  AZFc,  defied
sequencing by the usual methods.  Therefore, the AZFa section of the Y was initially selected to
study in detail, because of the apparent absence of multiple gene copies or Y-specific repeats in
that region (104,107).
AZFa, has a completely different, more conventional and non-repetitive structure  than
AZFb or AZFc, making this much less commonly deleted region of the Y  an ideal starting-off
point.  Therefore, the AZFa  region of the Y  chromosome was the first region of the Y  to  be
sequenced, and two functional genes were identified, USP9Y and DBY (104,107).  Sequencing of
these two genes in 576 infertile men and 96 fertile men revealed several sequence variants most of
which were inherited from the fertile father and of no functional consequence.  However, in one
case a de novo point mutation was found on USP9Y (a four base pair deletion in a splice-donor
site, causing an exon to be skipped and protein truncation).  This mutation was absent in fertile
relatives and represented the first case of a point mutation causing a single gene defect associated
with  spermatogenic  failure.    This  particular  region  of  the  Y  was  more  amenable  to  such  a
mutation  search  because  of  the  lack  of  sequence  repeats  which  plague  the  rest  of  the  Y
chromosome.  This finding offered a hint at what we might find if we were able to search for more
subtle gene defects in the larger areas of the Y  chromosome where most  of the testis  specific
genes have been located, such as AZFb and AZFc (64,102).
Studying AZFa also provided a good model for the interaction and overlapping functions
of  multiple  genes  which  sheds  light  on  the  “polygenic”  nature  of  the  genetic  control  of
spermatogenesis.  When the entire AZFa  region is deleted, taking out  both  DBY and USP9Y,
there is a more severe spermatogenic defect and the patient  is azoospermic.  However, when
there is only a specific point mutation of the USP9Y gene, we observed maturation arrest with a
few pachytene  spermatocytes  developing  into  mature  sperm  in  a  few  seminiferous  tubules.
Thus, the loss of DBY (the only other gene in the AZFa region) exacerbates the spermatogenic
consequences of the loss of USP9Y.  This finding in the AZFa region runs parallel to  previous
observations that  larger Y  deletions (which take out  more genes) are associated with  a  lesser
likelihood of finding sufficient sperm for ICSI (65).
Shortly  after  we  began  our  Y  chromosomal  mapping  study  of  infertile  men,
intracytoplasmic sperm injection (ICSI) with testicular and epididymal sperm retrieval methods
for  azoospermia  were  developed  (1,44-46,48-49,51,54,60,108).    Men  with  the  most  severe
spermatogenic defects causing azoospermia in the ejaculate could now have children.  Thus, at the
very moment in time that we had an effective treatment for severe male infertility, the reality that
male infertility is often of genetic origin, also became generally recognized.  Subsequently it wasSilber
demonstrated that these Y deletions would be transmitted to offspring as a result of ICSI (54-
55,59,65).  When sperm were recoverable in azoospermic or oligospermic men, there was  no
significant difference in fertilization or pregnancy rate with ICSI whether the man was Y-deleted
or not  (Table 1B).  Large defects resulted in complete azoospermia but  smaller  defects  were
associated  with  the  recovery  of  some  sperm  sufficient  for  ICSI,  and  even  occasionally
spontaneous offspring as well (109).Silber
WHY THE “Y”?
Why should the initial molecular efforts at defining the genetic causes of male infertility
have  concentrated  on  this  difficult  Y  chromosome  with  all  of  its  confounding  repeats,
polymorphisms, and degenerating regions?  The answer lies in the evolutionary history of the X
and Y chromosome.  Over the course of the last 240-320 million years of mammalian evolution,
the  X  and  the  Y  chromosome  have  evolved  from  what  was  originally  a  pair  of  ordinary
autosomes (Fig. 4) (64,103,110-115).  During that  evolution, just  as most  of the ancestral  X
genes were decaying because of the lack of meiotic recombination of the developing X and Y-
chromosomes, genes which control spermatogenesis arrived (by  transposition  or retroposition)
from autosomes to the Y (Fig. 5).  Once on the Y, these formerly autosomal genes amplified into
multiple copies, and achieved “greater prominence” (94,103).  Spermatogenesis genes that arrived
on the Y, but came originally from autosomes, include the well studied DAZ  and CDY genes
(94,98,116).  Other spermatogenesis genes on the Y have persisted from their original position on
the X and later became modified, and developed specific spermatogenic function on the Y.  These
genes also were amplified into numerous copies on the Y, such as the RBM genes (117-121).
Although DAZ is a very ancient, well-conserved gene, readily found to  be functional in
autosomes of c. elegas (worms), drosophila (fruit flies), xenopus (frogs), and rodents, it is only
found on the Y  chromosome of old world monkeys, apes, and humans (Table 2).    In  earlier
mammals and in non-mammalian species,  DAZ  homologues  are  otherwise  purely  autosomal.
RBM genes, however, are found on the mammalian Y as far back as the Y’s origin, as evidenced
by  its  presence  on  the  Y  of  marsupials  even  before  the  divergence  of  eutherian  from  non-
eutherian mammals.  Thus, RBM had its origin on the ancestral autosomes that evolved into the
mammalian X and Y-chromosomes.  The ancestral RBM  that  remained on the X chromosome
(RBMX) retained its “widespread” function, whereas RBM-Y, which persisted on the receding
Y chromosome, evolved a male-specific function in spermatogenesis amplified from 9 exons to 12
exons, and into numerous copies, most of which are nonfunctional.  But  at least one of them,
RBMY-1 in the AZFb region, retained its testis-specific function (119,121-123).
Indeed, even the SRY gene (the male sex-determining locus) is considered to originate from
the SOX3 gene on the ancestral X prior to differentiating into the SRY male sex-determining gene.
In fact, the evolution of a non-recombining male determining gene (SRY) is what actually began
the whole process of the Y chromosome’s evolution.  SOX-3 is a gene  on the X chromosome
which inhibits SOX-9 also on the X chromosome.  SOX-9 (on the X chromosome) is the gene
that  actually activates male sex determination.  SOX-3 evolved into  SRY  on  the  ancestral  Y
chromosome.  SRY inhibits SOX-3 from suppressing SOX-9, and thus  determines whether the
SOX-9 cascade of events leading to the formation of a testis takes place.  That was the beginning
of the transformation of an ordinary pair of autosomes into the modern X and Y. (Fig. 6) (113-
114,116,122,124).  
Genes associated with the non-recombining SRY region that  were specifically beneficial
for male function or antagonistic to female function, flourished on the evolving Y  chromosome
because it was a “safe harbor,” without  the detrimental effect of meiotic recombination which
would have otherwise allowed male-specific genes to be expressed in females (64,103,116,125).
In this way, “male benefit” genes have arrived and accumulated on the evolving Y  chromosome
over many millions of years via the three mechanisms of: ”transposition” from an autosome viaSilber
translocation, “retroposition” from an autosome via reverse transcription, and “persistence,” i.e.,
male modification of function from what was originally a gene on the ancestral X.  This process
gives the Y chromosome a very unique type  of “functional coherence” not seen elsewhere in the
human genome (Fig. 7) (64).  However, like with SRY, we should not be surprised to find that
many genes which are male-specific could be on the X as well, and sprinkled throughout the
genome.
FUNCTIONAL REPRODUCTIVE ANATOMY OF THE X AND Y CHROMOSOME
Translocations occur on a relatively frequent basis in any  species.  Over evolutionary
time, this  results in conserved, homologous genes of  different  species  residing  in  completely
different parts of the genome and in a relatively mixed-up array of genes in every chromosome,
where structural proximity has little or no relationship to function (64).  However, these random
transpositions (which over the course of time result in a chaotic lack of apparent organization of
the genome) have also allowed direct acquisition by the Y of genes that have a common function
to  enhance  male  fertility.    Selective  pressures  favor  the  process  of  spermatogenesis  genes
concentrating on the non-recombining portion of the Y chromosome in association with the male
sex-determining gene, SRY, particularly if these genes are of little benefit to females or actually
diminish “female fitness” (94,110-113,125-127,129).
Quite interestingly, the X chromosome, unlike autosomes, and unlike the Y chromosome,
has been remarkably conserved in all mammals, with little mixing of genes from elsewhere.  This
is because of the selection against disruption of development of the X-inactivation process in the
evolution of the X and Y (128).  In a later section, I will explain more lucidly the phenomenon of
X-inactivation.  Suffice it to say at this junction, unlike the autosomes, the X chromosomes of all
mammals are remarkably similar, and the Y chromosome has evolved into a specific functional
organization not seen elsewhere in the genome.
Genes which arrived on the Y, or which persisted on the degenerating Y from the ancestral
X, and gained prominence on the Y, underwent paradoxical processes of amplification, producing
multiple copies, and degeneration because of the failure of recombination.  DAZ  (as has been
discussed) was the first such gene which was identified in the AZFc region of the Y chromosome
by  our initial Y  mapping in azoospermic men (36).    DAZ  represents  the  first  unambiguous
example of autosome-to-Y transposition of a spermatogenesis gene, which is representative of a
generalized process that affects many other spermatogenesis genes, and indeed possibly explains
the relatively poor state of affairs of human spermatogenesis compared to that of other animals
(94,125).  Autosome-to-Y transposition of male fertility genes appears to be a recurrent theme in
Y chromosome evolution throughout all species.  The autosomal DAZ  gene  (in humans called
DAZ-L) is located on human chromosome 3, and on mouse chromosome 17.  At  some point
during the evolution from new world to old world monkey, about 30 million years ago, this DAZ
gene  arrived on the Y  by  transposition  from  what  is  now  human  chromosome  3,  and  there
multiplied to  produce four almost identical gene  copies.  This  process  was first depicted  for
DAZL and DAZ.  However, there are now known to  be other previously  autosomal genes or
gene families on the Y that are expressed specifically in the testis, and are also likely to  play  a
major role in spermatogenesis (Table 3) (64).Silber
The CDY gene arrived on the AZFc region of the Y  chromosome in a different fashion
than DAZ, via reverse transcription  (103).  The autosomal CDY gene  (CDY-L) is located on
mouse chromosome 13 and on human chromosome 6.  CDY’s intron-free homologue found its
way to the human Y actually prior to the arrival of DAZ, sometime after the prosimian line of
primates  separated  off,  approximately  50  million  years  ago  (Fig.  8).    It  did  so  by  reverse
transcription and, therefore, has very  few introns in marked contrast  to  CDYL, its  autosomal
homologue on chromosome 6, which is intron-rich (103).  The RBMY-1 gene, located on the
“AZFb” region of the Y chromosome, had its origin in our ancestral X chromosome, “persisted”
on the Y, and there it was modified into a testis-specific gene  (116,118-121,113,96).  As  the
evolving Y chromosome underwent decay because of lack of recombination, these “persistent”
genes (which were originally X chromosomal) diverged in sequence on the Y, and those which had
“male benefit” functions flourished (Table 4).  
The AZFa region of the Y chromosome is a little more complicated.  As the ancestral Y
began to recede in comparison to its paired X, it did so in stages and “strata”  over about 320
million years (Fig. 9).  There are four clearly definable strata on the X chromosome that decrease
in X-Y homology according to how early in their history they failed to recombine (103).  As  a
given stratum of the X failed to recombine with its Y counterpart, homologous X-Y genes in that
stratum diverged in sequence structure (Fig. 6).  The most recent areas of non-recombination of X
genes is located most proximally on the X and the most ancient areas of non-recombination are
located most distally on the X.  The AZFa  region of the Y  chromosome diverged from the X
fairly recently in its evolutionary history and, therefore, has a much more conventional sequence
structure, with much greater homology to  its  counterpart  on the X.  The two  genes in AZFa
(USP9Y and DBY) both play  an important  role in spermatogenesis, in that  deletion of AZFa
results in a complete absence of sperm.  Yet they have very close homologues on the X, and are
still ubiquitously transcribed (104,107).
Regardless of the method of arrival  of  spermatogenesis  genes  to  the  non-recombining
portion of the Y, this region would inevitably face, and likely succumb, to powerful degenerative
forces during subsequent evolution (94).  Saxena postulated that, “perhaps the rate of acquisition
of  male  fertility  genes  approximates  the  rate  of  subsequent  degeneration,  resulting  in  an
evolutionary  steady  state.    In  contrast  to  the  extreme  evolutionary  stability  of  the  X
chromosome, at least in mammals, individual male infertility genes might not be long lived, in an
evolutionary sense, on the Y chromosome.”  
Our  emphasis  on  the  Y  chromosome  for  locating  spermatogenesis  genes  to  help  in
elucidating the causes of male infertility makes sense, because the Y  has collected for us genes
that otherwise would be hidden throughout the genome.  However, it would be naïve to assume,
in view of the evolutionary history  of the X and the Y, that  there are not  equally  powerful
components  for  regulating  spermatogenesis  located  also  on  the  X  chromosome  and  on  the
autosomes.  Some have speculated that  the instability  of the Y  chromosome may  lead  to  an
inexorable decline in sperm production  in the evolution of any  species, unless there  is  either
sperm competition within the mating pattern of the species, or a method of continual recruitment
of new spermatogenesis genes to  the  Y  chromosome  with  subsequent  amplification  prior  to
ultimate degeneration (125).  The Y chromosome is a favorable place to begin a molecular searchSilber
for genes that affect male fertility.  But the very reason for starting with the Y emphasizes the
likelihood of finding more such genes hiding throughout the genome.
PARALLEL  AND  INDEPENDENT  EVOLUTION  OF  X  AND  Y  CHROMOSOMES  IN
HUMANS  AND  ANIMAL  MODELS:THE ORIGIN  OF  X-INACTIVATION  (e.g.,  worms,
flies, even fish)
Sex chromosomes have evolved independently many times in different genera with  the
same common theme.  The chromosome with  the sex-determining gene  progressively loses the
ability  to  recombine  with  its  mate,  accumulates  mutations,  and  embarks  on  an  inexorable
deterioration.  For example, the mammalian Y chromosome and the Drosophila Y  chromosome
(not to mention the ZW system in avians) have nothing in common with each other except their
name, and the fact that they do not recombine with their larger counterpart, which is called the X
chromosome.  The X and Y-chromosomes evolved completely separately and differently in each
of these well studied groups of species, but  remarkably they  evolved  via  the  same  common
evolutionary theme.  
If the Y chromosome of Drosophila has a deletion, the Drosophila is sterile.  If the Y
chromosome of the mouse or human has a deletion, the mouse or human is sterile.  In any species
thus far studied, if the Y chromosome has a significant deletion, that species is sterile.  However,
the genes that would have been deleted on the Drosophila Y, or the mouse Y-chromosomes, are
not the same genes that are deleted in the human Y.  For example, the homologue of the human Y
DAZ gene on Drosophila is autosomal, (the so-called “boule” gene), just as it is also autosomal in
the mouse (DAZLA), and the deletion of this  autosomal gene  in Drosophila, or in the mouse,
results in sterility just as readily as deletion of the Drosophila Y  or the mouse Y  chromosome
(96,28,97).  Deletion of the DAZ genes on the Y chromosome of humans often does not result in
complete absence of spermatogenesis, possibly because the ancient DAZ autosomal homologue
on chromosome 3, rescues spermatogenesis to  some small extent.  Deletion  of  certain  AZFb
genes, however, usually result in total absence of sperm, probably because there are no effective
autosomal or X homologues to rescue spermatogenesis when these genes are deleted.
The same pattern is found in all species studied.  The X and Y begin as a pair of ancestral
autosomes in which a male-determining gene  (which does not  recombine with  its  homologue)
begins the inexorable process  of decay into  what  then  becomes  a  Y  chromosome.    In  some
Drosophila, the Y chromosome has disappeared altogether, and the resultant XO male is sterile.
Although the human Y chromosome (or for that matter, any of the mammalian Y chromosomes)
has no nucleotide sequence similarity at all to the fruit fly’s Y chromosome, the same mechanism
of accumulation of spermatogenesis genes to  a decaying male  sex-determining  chromosome  is
operating (125).  Thus,  the Y  chromosome of the Drosophila, (and to  some  extent  even  the
mouse) is quite different than the Y chromosome of the human, but yet  they  appear  to  be the
same because of the common two evolutionary themes in the development of the Y.   One theme
is its gradual decay from what was its autosomal homologue, but is now the X chromosome, and
the second theme is its growth from acquisition and accumulation of male benefit specific genes
from other parts of the genome.
This  evolutionary  mechanism  of  degeneration  of  the  Y,  and  accumulation  of
spermatogenesis genes may explain the relatively high frequency of male  infertility  and  poorSilber
sperm quality in species (like ours) that have minimal sperm competition.  It  may also explain
the phenomenon of X inactivation, the high frequency of XO human stillbirths, and the survival
of some XO concepti as Turner’s Syndrome children.
The ancestral autosome which is to become the X chromosome develops a process first of
hyperactivation, and then X inactivation, to make up for the decay of homologous alleles on what
is now becoming the Y chromosome (129,128).  As the X retained, and the Y gradually lost, most
of these ancestral genes, expression of the X had to, at first, be increased to compensate for the
male’s loss of these genes, and X inactivation had to develop in the female for X genes whose Y
homologue  had  eventually  disappeared  (Fig  10).    The  problem  of  X  chromosome  dosage
differences in males and females is solved by  inactivation in the female of one of the two  X
chromosomes combined with up regulation of the remaining X chromosome in females and the
single X chromosome of males.  This mechanism also insured the remarkable conservation and
similarity of the X chromosome in all mammalian species.
An understanding of the evolution of X-homologous Y genes losing their general cellular
functions, requiring up  regulation, and inactivation  of  X  genes  on  one  of  the  two  female  X
chromosomes, helps to clarify the different stages of evolutionary development of the mouse and
human Y.  The RBMY  gene  is a testis-specific male benefit spermatogenesis  candidate  gene.
RBM’s homologue on the X (RBMX) developed no male specific expression, but  retained its
general cellular housekeeping function.  Thus,  RBMX  would be expected to  behave like an X
gene with no Y counterpart and probably undergo X inactivation (Table 5).  As a related example,
human ZFX and ZFY genes are very closely related homologues on the X and Y  chromosome,
both of which have general cellular housekeeping functions that  are critical for life.  Therefore,
ZFX escapes X-inactivation in the female and ZFY is, therefore, probably  one of the Turner
genes (64,129).  However, the mouse is quite different.  In the mouse, ZFY appears  to  have
evolved a male-specific function, and, therefore, ZFX in the mouse has a general housekeeping
function not  shared with  its  Y  homologue.  Thus,  ZFX  in  the  mouse  is  X-inactivated,  even
though in the human it is not.
Similarly, RPS4X and RPS4Y are another homologous pair of genes on the X and Y, both
of which have equivalent housekeeping functions in the human.  Therefore, in the human RPS4X,
similarly to ZFX, is not subject to X-inactivation because there are functional transcripts in men,
from the X and Y, and in women from the two X’s.  In mice, however, RPS4Y has not only lost
its function in evolution, but has degenerated out of existence.  Therefore, in the mouse RPS4X is
subject to X-inactivation, just as most of the genes on the X chromosome in all animals require
X-inactivation if they don’t have a functioning homologue on the Y.  
This summary of the evolutionary history of our X and Y chromosome explains why the
Y  chromosome was a good place to  start  in our molecular search  for  spermatogenesis  genes.
However, it is clear that numerous genes from throughout the genome, though less well studied,
also impinge on spermatogenesis, and may thus be transmitted to ICSI offspring.  
KARYOTYPE OF INFERTILE MALES AND OF ICSI OFFSPRING  
The incidence of cytogenetically recognizable chromosomal abnormalities in the offspring
of ICSI patients is acceptably very low, but much greater than what would be anticipated in a
normal newborn population.  Follow-up of the first 1,987 children born as a result of ICSI hasSilber
been meticulously studied and reported by the originators of ICSI in the Dutch-Speaking Free
University of Brussels (Bonduelle et al., 1995, 1996, 1998a, 1998b, 1999).  In 1,082 karyotypes
of ICSI pregnancies, 9 (0.83%) had sex chromosomal abnormalities, including 45,X (Turners), 47,
XXY (Klinefelter’s), 47, XXX and mosaics of 47, XXX, as well as 47, XYY (Table 6).  This is a
very low frequency of sex chromosomal abnormalities, but nonetheless is four times greater than
the expected frequency of sex chromosomal abnormalities  in  a  newborn  population  (0.19%).
Obviously the 45,X and 47,XXY children will be infertile (0.5%).  Four (0.36%) of the 1,082
offspring had de novo balanced autosomal translocations or inversions.    These  children  were
apparently normal, but this incidence of de novo balanced autosomal translocations is five times
greater than what  would be anticipated in  a  normal  newborn  population  (0.07%),  and  these
children might also be suspected of growing up to be infertile (0.36%).  
There were ten cases of translocations inherited from the infertile male (.92%), and these
children are also likely to be infertile.  Nine of these ten were balanced translocations in normal
newborns.  The one (0.09%) unbalanced translocation, was diagnosed at amniocentesis and was
terminated.  Since  approximately  2%  of  oligospermic  infertile  males  have  chromosomal
translocations (compared to a controlled population of 0.25%), it is not surprising that 0.9% of
ICSI offspring would inherit such a translocation from their father (Van Assche et al., 1996).
Thus, on purely conventional cytogenetic evidence, approximately 2% of ICSI offspring might be
expected to share their father’s infertility.
The remarkable five-fold increase in de novo balanced translocations among ICSI offspring
(0.36% compared to 0.07%) is of great concern.  Only 20% of balanced
translocations are de novo, and 80% are inherited (130).  De novo balanced translocations are
usually of paternal origin (84.4%) and obviously most of the inherited balanced translocations in
ICSI patients would come from the father (10,131).  Balanced translocations which are associated
with male infertility thus originally arose de novo in the testis of an otherwise fertile father, or his
paternal ancestors, in 0.07% of a control population.  Much more frequently, de novo balanced
translocations (albeit still a low percentage of only  0.36%) arise in the testis  of infertile men
undergoing ICSI and are transmitted to their offspring.  The deficient testis appears not only to
be at risk of transmitting inherited autosomal cytogenetic defects, but also of producing a greater
number of de novo cytogenetic defects.  
The incidence of congenital abnormality in ICSI children (2.3%) is no greater than in every
normal population studied (5-9).  Even the few reported ICSI offspring of Klinefelter’s patients
have  been  chromosomally  normal  (132-135).    There  is  no  greater  incidence  of  autosomal
aneuploidy than what is predictable from maternal age.  Sex chromosome aneuploidy (0.83%) in
ICSI offspring is not an unacceptably high incidence, although it is clearly greater than normal
(0.19%).  Thus, the evidence based on cytogenetic and pediatric follow-up of ICSI offspring is
very reassuring, despite the probable occurrence of infertility and sex chromosomal disorders in a
small percentage of cases.  
Y DELETION STUDIES OF ICSI OFFSPRING
Microdeletions on the long arm of the Y chromosome do not appear to adversely affect
the fertilization or pregnancy results either in severely oligospermic men, or in azoospermic men
from whom sperm were successfully retrieved (65).  There have been concerns registered that theSilber
ICSI results might be poorer with  Y-deleted men, but  in larger series,  that  has  not  been  the
experience (90,136) (Table 1B).
Thus far, all of our male offspring from Y-deleted men have had the same Y  deletion as
their infertile father (59).  Fathers, brothers, and paternal uncles of the infertile men, were also
examined for Y deletions and fertility.  Y deletions in our infertile males were for the most part de
novo.  That is, the fertile fathers of infertile Y-deleted patients had no Y deletion.  However, all
male offspring from ICSI procedures involving these Y-deleted men had their father’s Y deletion
transmitted to them without amplification or change (Fig. 11).
The idea that the Y deletion would be transmitted to the son is not as obvious as it might
at first seem.   If  a  few  foci  of  spermatogenesis  in  the  testis  of  a  severely  oligospermic  or
azoospermic Y-deleted man were present  because of testicular mosaicism, it would seem very
possible that  the few areas of normal spermatogenesis within such a deficient  testis  of  a  Y-
deleted man might actually have a normal Y chromosome.  In that event, one could have expected
the sons of these patients undergoing ICSI not to be Y-deleted.  For example, thus far all the sons
of Klinefelter’s patients  have been normal 46, XY (132-135).  Thus,  it is not  at all obvious,
intuitively, that this Y deletion had to be transmitted to the son.  However, increasing experience
seems to indicate that the Y deletion of the sterile father is, in fact, transmitted to the son, and we
no longer have to just speculate about it.  
It remains to be determined whether non Y-deleted fertile or infertile men have mosaic
deletions in their testis.  If so, then de novo Y deletions would also be found more frequently in
the brothers of our Y-deleted patients, or in ICSI offspring of infertile men (even those who have
no Y deletion) than would otherwise be expected to occur in a normal newborn population (30).
However, what we now know from the detailed sequence studies of the AZFa and AZFc regions
of the Y chromosome gives us a much better picture of how Y  deletions commonly occur, and
how they are transmitted to offspring.
SEQUENCING OF THE Y CHROMOSOME, MECHANISM OF DE NOVO APPEARANCE
OF  Y  DELETION,  AND  TRANSMISSION  OF  MALE  INFERTILITY  TO  FUTURE
GENERATIONS
The first region of the Y chromosome that was completely sequenced was AZFa because
it was a region of the Y  with  very  little repetitive sequences, and was relatively amenable to
study (104).  Now, the more daunting AZFc region (with large areas of sequence identity)  has
also  been  very  recently  sequenced  (102).    The  sequence  of  AZFa,  revealed  it  to  span
approximately 800,000 nucleotide bases (800 KB), and was bounded on each side by a proximal
breakpoint area and a distal breakpoint of around 10,000 bases (10 KB) of 94% sequence identity
with each other.  Furthermore, the sites of these breakpoints (even with conventional mapping)
in most infertile men with AZFa deletions were indistinguishable from each other.  Within these
10  KB  breakpoint  regions,  the  site  of  AZFa  deletion  almost  uniformly  fell  within  smaller
domains (447 BP to 1285 BP) of these 10,000KB breakpoints that exhibited absolute sequence
identity  (107).  Indeed, the  sequencing  of  deletion  junctions  of  most  AZFa-deleted  patients
revealed that homologous (”illegitimate”) recombination had occurred between identical areas of
proviruses  that  bounded  each  side  of  this  800,000  nucleotide  region,  allowing  the  entire
intervening segment to drop out.  The repeat areas of absolute sequence identity  proximal andSilber
distal  to  a  common  area  of  deletion  clarifies  the  mechanisms  for  Y  deletions  to  occur  so
frequently.  With AZFa, the sequence repeats are caused by an ancient intrusion of a retrovirus
into that region of the human Y.  For AZFc,  the situation is similar but  occurs for a different
reason on a vast scale of unprecedented and much more massive lengths of repeats.
The sequence of AZFc reveals the same mechanism for deletions to occur as for AZFa,
but on a grander scale.  Examination of the AZFc sequence revealed symmetries of unprecedented
scale and precision.  Figure 12 is a compressed dot-plot of the AZFc sequence in which perfect
matches of at least 500 nucleotide bases are summarized by  the same  color  (See  Figure  12).
There are no single-copy sequences in the 4.5mB region analyzed.  There are six distinct families
of amplicons (massive repeat units) ranging from 14kb to 678kb in length, spanning the entirety
of AZFc, as well as another million base pairs proximal to AZFc.  There are six massive inverted
repeats and three massive direct repeats.  Large domains of absolute sequence identity  become
easy  sites for  dropout  of  large  chunks  of  DNA,  since  the  boundaries  of  absolute  sequence
identity can “illegitimately” recombine with each other (106,102).  Amplification and inversions
in the most ancient areas of divergence from the X, create a perfect environment for subsequent
deletion  and  degeneration.    The  very  repetitive  nature  of  the  Y  chromosome,  that  made
sequencing and finding small deletions or point  mutations so difficult, is also the cause of its
instability  over  an  evolutionary  time  frame,  as  well  as  in  our  current  infertile  male  patient
population.  Y deletions large enough to be detected with our currently outmoded maps occur in
about 1/2000 births because of these vast  areas of absolute sequence identity.    However,  an
analysis  of  the  complete  sequence  of  AZFc  indicates  that  smaller  deletions,  involving  only
limited areas of AZFc, have been completely missed until now by conventional STS mapping.
The AZFc region of the Y (which is the most  common “microdeletion” site, spans  3.5
megabases of DNA, and is thus hardly a “microdeletion” (as it is often called).  It is composed of
three giant palindromes constructed from six families of amplicons (i.e., long areas of absolute
sequence identity).  This “microdeletion” site, AZFc, contains 19 transcriptional units composed
of seven different gene  families,  only  one  of  which  is  DAZ  (which  comes  in  four  separate
copies).  This huge 3.5 mB AZFc region is bounded on each side by nucleotide sequences that are
229,000 long of near absolute sequence identity (99.9%).  But within AZFc are multiple sites for
smaller deletions that could not possibly be detected by current methods because the PCR would
amplify from one area of AZFc even if it did not  amplify from a missing area with  the same
sequence.  Unlike AZFa, the “breakpoints” of sequence identity for AZFc did not come from an
ancient retrovirus, but rather from the very nature of the evolution of the Y chromosome caused
by the failure of recombination.  
In retrospect, it is apparent why all previous mapping and sequencing efforts relying on
techniques  that  include  STS  content  analysis,  restriction  mapping,  Southern  blotting,  and
fluorescent in-situ hybridization, failed to  decipher  AZFc’s  organization.    These  approaches
simply could not distinguish amplicons that  display  the size and sequence similarity found in
AZFc.  The extraordinary structure of the AZFc complex, and presumably other testis-specific
regions of the Y, could only be unraveled by accurate genomic sequencing of clones drawn from a
single Y  chromosome, and an analysis of sequence family variants (SFV’s) identified through
such sequencing.  There are many amplicon pairs (and inverted repeats) in AZFc in addition to
B2/B4.  There are similar repeats elsewhere on the Y outside of AZFc.   This  “huge” region ofSilber
what used to be called a Y “microdeletion” spans transcriptional units that appear to affect only
one cell lineage, spermatogenesis.  The Y chromosome is a preferential site for “gene building” of
testis-specific transcriptional units.  Thus, autosomal DAZ has 11 exons, whereas each one of
the four copies of DAZ on the Y has 28 exons and (as well as 19 pseudoexons).  It is, therefore,
safe to anticipate finding a much greater number of cases of male infertility to  derive from Y
chromosomal aberrations.  There are multiple areas on the Y  that,  like the AZFc  region, have
either  direct  or  inverted  sequence  repeats.    Direct  repeat  sequences  will  result  in  common
deletions  due  to  homologous  recombination.    Inverted  repeats  will  result  in  “isodicentric”
translocations also because of homologous recombination.  Thus,  we can expect to  find many
other, smaller deletions on the Y of infertile men that have previously escaped detection by the
crude, non-sequence based STS mapping currently available.
The proximal and distal breakpoint regions of AZFc  deletions correspond to  just  two
members (B2 and B4) of one of the six-amplicon families.  There are seven different families of
genes with 19 separate transcriptional units within AZFc (3.5mB), and eleven families of genes
with 27 separate transcriptional units within the palindromic complex that spans AZFc (4.5mB).
The seven gene families within AZFc are BPYx, DAZ, CDY-1, CSPGL4Y, GOLGA2LY, TTY-3
and TTY-4.  The four additional gene families within the palindromic complex that  are located
proximal to AZFc (RBMY-1, PRY, TTY5 and TTY6) are located in the distal most  region of
what used to be called AZFb.   All these genes are specifically transcribed in the testis.   The
“designations” of AZFb and AZFc no longer seem tenable, because the basic construction of the
palindromic complex containing these  repeat  units  and  genes  extends  for  almost  one  million
nucleotides proximal to AZFc.
Therefore, it is likely that  smaller deletions, taking out  less genes, or point  mutations,
involving just one or two copies of identical genes that normally occur in multiple copies, could
account  for  many  more  cases  of  male  infertility,  or  perhaps  more  moderate  degrees  of
spermatogenic failure (e.g. > 2x10
6 to  20x10 sperm/cc).  The large “micro-deletions”  thus  far
reported in the literature are for the most part de novo, but certainly some men with these large
deletions, despite severe oligospermia, can naturally father children (about 4%).  Men with more
moderate degrees of oligospermia  may  father  children  even  more  easily,  and  thus  smaller  Y
deletions causing more moderate degrees of male infertility may be less likely to be of de novo
origin.  In any event, as more and more genetic causes of spermatogenic failure (severe or mild)
come to light, there is an increased awareness of the likely transmission of male infertility to
future generations.
THE X CHROMOSOME AND MALE INFERTILITY
It has been theorized that the Y is not the only sex chromosome that accumulates genes
which benefit spermatogenesis over an evolutionary time span  (137,110,138,139).  As  the  X
chromosome (240 to 320 million years ago) differentiated from the Y, the sexually antagonistic
gene theory favors the emergence of genes on the X also that benefit the heterogametic sex (with
mammals of course, that is the XY male) and that are detrimental to  the homogametic sex (the
XX female) if these genes are recessive.  For example, a rare recessive evolutionary mutation on
the X that favors spermatogenesis would be preferentially passed on to male offspring who by
virtue of a higher sperm count would then continue to pass down this favorable X mutation inSilber
turn to his offspring.  Such a recessive mutation (favorable to spermatogenesis) in an autosome
would be lost  to  future generations.  Thus,  we can also anticipate an accumulation on the X
chromosome (as well as on the Y) of male benefit recessive genes.
In fact, RT-PCR subtraction studies of spermatogonia in mice have demonstrated that  a
large fraction of genes which are expressed exclusively in pre-meiotic male germ cells, are indeed
X chromosomal in origin (140).  Eleven of the 36 genes that were expressed specifically in mouse
spermatogonia were found exclusively on the X chromosome.  Since the X chromosome is so well
conserved in all mammals (as explained earlier by the universal development of X inactivation in
mammalian evolution), it seems very  likely that  evolution has also conferred on the human X
chromosome a large portion of the burden for spermatogenesis.  Thus,  a search for detrimental
mutations on the human X in infertile males is also likely to be very rewarding.  Thus, the failure
to identify a Y deletion gives no assurance whatsoever that a genetic cause for infertility won’t be
transmitted to the ICSI offspring either via the Y, the X, or even autosomes.
CONCLUSIONS
The presence of Y  deletions does not  decrease the  fertilization  or  pregnancy  rate  for
azoospermic and severely oligospermic (<2x10
6) men.  Thus far the sex ratio of delivered children
is apparently equal and the children are karyotypically normal.  However, the Y  deletion (and
presumably infertility) is transmitted to the male offspring 59).  Although using standard STS
mapping,  Y  deletions  occur  in  only  10%  of  azoospermic  and  severely  oligospermic  men,
sequenced based mapping (now just available) is certain to increase that percentage significantly.
There are most likely many spermatogenesis genes involved in male infertility, and we
have  barely  scratched  the  surface  with  what  have  been,  up  till  now,  very  crude  mapping
techniques  on  the  Y  chromosome.    Whether  or  not  these  gross  “microdeletions”  currently
reported in the literature are found in an infertile male patient, does not obviate the likelihood of
there being a genetic cause for his azoospermia or severe oligospermia.  If a defective gene  (or
genes) is located on his Y  chromosome,  then  his  male  offspring  will  most  likely  inherit  his
problem.    However,  there  are  also  many  genes  on  the  X-chromosome,  and  throughout  the
genome, that  impinge upon  spermatogenesis that  are not  thus  far identified  by  our  currently
crude mapping procedures.  The  recognized  failure  of  any  conventional  therapy  to  improve
spermatogenesis infers a genetic origin for most  spermatogenic defects (141,142,136).    These
numerous genes may also be responsible for many cases of male infertility.  Therefore, sons, and
even daughters, may inherit the defect or be carriers.
It is clear that a negative Y microdeletion assay by currently popular methods does not
rule out genetic abnormality.   Therefore, in our view, genetic counseling should be provided to all
infertile males, whether or not an abnormality is detected and whether or not Y deletion assays
have  even  bothered  to  be  performed.    Although  karyotyping  certainly  should  be  routinely
performed for infertility patients  (because  of  the  risk  of  miscarriage  and  abnormal  offspring
resulting from either sex chromosome abnormalities, or unbalanced translocations),  Y  deletion
testing may not be mandatory yet, because it is still very crude, and negative results should not
be at all reassuring.  Furthermore, some “deletions” may only  be polymorphisms,  and not  of
clinical significance.  It  is  apparent  that  there  is  likely  to  be  frequent  transmission  of  maleSilber
infertility from the ICSI father to his male (or even female) offspring regardless of current testing.
Every couple must  decide  for  themselves  whether  they  wish  to  consider  this  risk.    In  our
experience, most such couples, even when well informed, choose to have ICSI despite this risk.
Thus, continued long-term clinical and molecular study of ICSI offspring is mandatory.Silber
POST-COURSE QUESTIONS
1. Y deletions (some not detectable with currently popular assays) are associated with:
a. Varicocele.
b. Moderate oligospermia.
c. Severe oligospermia.
d. Azoospermia.
e. B, C, and D.
2. Y deletions result from:
a. Varicocele.
b. Excessive heat.
c. The desire to make more money.
d. Illegitimate homogous recombination between large areas of absolute DNA  sequence
identity.
e. Gene mutations.
Answers:
1. E
2. DSilber
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Table 1a:  Percentage of Chromosome Abnormalities Observed in Seven Series of Infertile Men
(Azoospermic and Oligospermic) Compared to Normal Newborn Population
All Sex
References Number Chromosomes Autosomes Total
Total 7,876 295  (3.8) 104  (1.3) 399  (5.1)
(Azoospermic and
Oligospermic)
Newborn  94,465 131  (0.14) 232  (0.25) 366  (0.38)
Infants (Control)
Van Assche et al., 1996Silber
Table 1b:  Results of ICSI in Y-Deleted Versus Y Non-Deleted Men with  Severe Oligospermia
(<2 x 106) and Azoospermia (Non-Obstructive)
Y-Deleted (<2 x 10
6) Not Y-Deleted (<2 x 10
6)
# Patients (with sperm) 23 205
# Cycles (with sperm) 45 312
# Eggs 508 3291
# 2PN (289) 57% 1849) 56%
# Pregnant (17) 38% (112) 36%
# Deliveries (13) 29% (81) 26%
# Babies 18 99
# Boys 10 43
# Girls 8 56
Silber, Oates, Brown, Page (2001)Silber
Table 2:  Genes of the DAZ Family in Vertebrates and Drosophila
Y Chromosomal Autosomal
Human DAZ cluster (at least DAZL
4 copies, > 99% identical (chrom. 3)
Mouse DAZL (Dazla)
(chrom. 17)
Xenopus Xdazl
Drosophila boule
C. elegans daz-1Silber
Table 3:  Arrival of Spermatogenesis Genes to Y Chromosome
Y Gene Ancestral Gene
Transposition DAZ (AZFc) DAZL (autosomal)
Human-Y Mouse 17    Human 3
Retroposition CDY (AZFc) CDYL (autosomal)
Human-Y Mouse 13    Human 6
Persistence RBM (AZFb) RBMX
Human-Y and Mouse-Y Mouse X    Human X
Persistence SRY SOX-3Silber
Table 4:  Persistence on Y of RBM X
Y Gene Ancestral Gene
SRY SOX-3
Determines Male Sex No male specific function
RBM-Y RBM-X
Male specific function No male specific function
Numerous copies One copy
Many degenerate
Same in all therian mammalsSilber
Table 5:  Persistence on Y of X Genes
Y Gene Ancestral X Gene
SRY SOX-3
Determines male sex No male specific function
RPS4-Y RPS4-X
Human Housekeeping Housekeeping
Ubiquitous Ubiquitous
Turner Gene No X-inactivation
Mouse No RPS4-Y Housekeeping
Evolved out of existence Is X-inactivated
ZFY ZFX
Human Housekeeping Housekeeping
Ubiquitous Ubiquitous
Turner Gene No X-inactivation
Mouse Male specific function only Housekeeping
Two copies only Ubiquitous
Is X-inactivatedSilber
Table 6:  Karyotype Anomalies in 1,082 Prenatal Diagnosis
Percent
Abnormal Karyotypes Maternal in
On 1,082 Prenatal Tests                     Age (years)      Number           Percent            
            Literature
De novo chromosomal aberrations 18 1.66 0.445
Sex-chromosomal: 9 0.83 0.19, 0.23
45, X 37
46, XX/47, XXX 44
47, XXX (2 children) 32, 37
47, XXY (4 children) 26, 28, 28, 32
47, XYY 25
Autosomal: 9 0.83 0.21, 0.61
Trisomy 21 (5 children) 32, 33, 37,
41, 41 5 0.46 0.14
structural 4 0.36 0.07
46, XXY, t (4;5) 30x
46, XX, t (2;15) 30
46, XX, t (2;13) 36
46, XX, inv (1qh) 39
Inherited aberrations 10 0.92 0.47
balanced 9 0.83 0.45
unbalanced 1 0.09 0.023
Total aberrations 28 2.5 0.92, 0.84
de novo + inherited
(Bonduelle et al., 1995; Bonduelle et al., 1996; Bonduelle et al., 1998;  Bonduelle et al., 1999)Silber
LEGENDS
Figure 1a/1b: Karyotype  of  the  azoospermic  male  with  cytogenetically  visible  Yq  deletion
compared to karyotype of a azoospermic male with a normal Y chromosome.
Figure 2: Y chromosome map based on STS interval markers and their corresponding X-
homologous and testis specific gene.
Figures 3a: Typical early deletion map of azoospermic and severely oligospermic men with
chromosomal micro deletion.
Figures 3b/3c: More refined, later deletion maps of azoospermic and severely oligospermic men.
Figure 4: Figurative  outline  of  evolutionary  degeneration  of  one  chromosome  with  the
testicular  determining  factor  (TDF)  gene  which  doesn’t  recombine  with  its
homologue, resulting eventually in a Y chromosome
Figure 5: Over the course of evolution, the Y  chromosome descended from the  ancestral
autosome that developed the SRY male-determining gene.  The Y  then attracted
male-specific genes by three mechanisms.  (Lahn and Page, modified, 1999b)
Figure 6: Graphic depiction of X-homologous genes on the Y chromosome representing four
different  stages  of  a  divergence  from  its  original  ancestral  X  showing
corresponding X and Y homologous genes.  Note  that  SOX3 and RBMX  come
from the earliest region of sequence divergence and correlate with  the SRY  gene
and the RBMY gene.  (Lahn and Page, 1999a)
Figure 7: The Y chromosome has a remarkable functional coherence not  seen in any  other
chromosomes.  Genes depicted above are X-homologous because of their equal
similarity to genes on the X chromosome.  Genes depicted below are Y-specific
genes which are  testis  specific,  expressed  only  in  the  testis,  and  have  no  X-
homologues.  (Lahn and Page, modified, 1997)
Figure 8: Whereas DAZ  was transposed  to  the Y  chromosome approximately 30 million
years ago  (after  the  divergence  of  old  world  and  new  world  monkeys),  CDY
arrived on the Y chromosome much earlier (50 million years ago) by a process of
reverse transcription.  (Lahn and Page, 1999b)
Figure 9: The X and the Y chromosome develop in mammals at the time of divergence the
avian and mammalian line by a series of four well defined inversions.  The earliest
inversions (region 1 on the X) have the least similarity to their Y-homologue, and
genes in the most recent area of divergence (region 4) have the greatest sequence
similarity of their counterpart on the Y.  (Lahn and Page, modified, 1999a)
Figure 10: X-inactivation develops after X-linked hyper expression as a pairing mechanism
between the evolving X and Y chromosomes to compensate for decay of X genes
on the evolving Y.  (Jegalian and Page, 1998)
Figure 11: The AZFc Y deletion present in the azoospermic or severely oligospermic father
is not present in his father, but is transmitted to his sons via ICSI.  (Page, Silber,
Brown, 1999)
Figure 12a: Amplicons and palindromes in 4.5-Mb portion of the human Y chromosome that
includes AZFc.   Dot-plot  in which region’s sequence  is  compared  with  itself.
This compressed, triangular plot  avoids redundancies and false symmetries that
would appear in a conventional square plot.  Amplicons of various families (blue,Silber
turquoise, green, red, gray and yellow arrows) are shown at the base of the plot.
Each dot within the plot represents a perfect match of 500 bp.  Direct repeats are
shown as horizontal lines, inverted repeats  as vertical lines and palindromes as
vertical lines that nearly intersect the baseline.  Palindromes P1, P2 and P3 are
indicated, as  are  two  smaller  palindromes,  P1.1  and  P1.2,  that  lie  within  P1.
Tinted squares reflect  pairs  of  amplicons  with  nearly  identical  sequences;  the
adjacent  numbers  denote  substitutions  per  10  kb.    Gray  diagonal  lines  mark
amplicon boundaries.  Selected amplicons (b1, t1, t2, b2, g1, r1, r2, b3, g2, r3, r4,
g3  and b4) are identified, as are sequences that  occur  once  within  the  4.5-Mb
region (u1, u2 and u3).  Orientation with respect to the centromere (cen) and long-
arm telomere (qter) is shown.  The full annotated sequence of the 4.5-Mb region is
available in Web Tables A, B and C and Web Note  A.  Kuroda-Kawaguchi T,
Skaletsky H, Brown LG, Minx PJ, Holland SC, Waterston RH, Wilson RK, Silber
S, Oates R, Rozen S and Page D.  The AZFc region of the Y chromosome features
massive  palindromes  and  uniform  recurrent  deletions  in  infertile  men.    2001,
Nature Genetics 29, 279-286.
Figure 12b: Sequence-based map of STSs, deletions, transcription units and autosomal
homologies. Kuroda-Kawaguchi T, Skaletsky H, Brown LG, Minx PJ, Holland SC,
Waterston RH, Wilson RK, Silber S, Oates R, Rozen S and Page D.  The AZFc
region of the Y chromosome features massive palindromes and uniform recurrent
deletions in infertile men.  2001, Nature Genetics 29, 279-286.Silber
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